New sustained-release intraarticular gel formulations based on monolein for local treatment of arthritic diseases

References

• Symmons D, Mathers C, Pfleger B. Global burden of osteoarthritis in the year 2000. World Health Organization [Online] (WHO), 2006. Available at: www.who.int/entity/healthinfo/statistics/bod_osteoarthritis.pdf ( Accessed 19 july 2012).
   Google Scholar
• Balazs EA. The Physical Properties of Synovial Fluid and the Special Role of Hyaluronic Acid in Disorder of the Knee. Helfet A, ed. Philadelphia: T.B. Lippincott Company, 1974:63–75.
   Google Scholar
• Gerwin N, Hops C, Lucke A. (2006). Intraarticular drug delivery in osteoarthritis. Adv Drug Del Rev, 58:226–242.
   PubMed Web of Science ®Google Scholar
• Sarzi-Puttini P, Cimmino MA, Scarpa R, Caporali R, Parazzini F, Zaninelli A, Atzeni F, Canesi B. (2005). Osteoarthritis: an overview of the disease and its treatment strategies. Semin Arthritis Rheum, 35:1–10.
   PubMed Web of Science ®Google Scholar
• Buckwalter JA, Martin JA. (2006). Osteoarthritis. Adv Drug Deliv Rev, 58:150–167.
   PubMed Web of Science ®Google Scholar
• Uthman I, Raynauld JP, Haraoui B. (2003). Intra-articular therapy in osteoarthritis. Postgrad Med J, 79:449–453.
   PubMed Web of Science ®Google Scholar
• Bellamy N, Campbell J, Gee TL, Bourne R, Wells G. (2009). Intraarticular corticosteroid for treatment of osteoarthritis of the knee (review). Cochrane Database Syst Rev:CD005328.
   Google Scholar
• Scale D, Wobig M, Wolpert W. (1994). Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Curr Therap Res, 55(3):220–232.
   Web of Science ®Google Scholar
• Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K. (1985). Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis, 44:817–872.
   PubMed Web of Science ®Google Scholar
• Brown TJ, Laurent UB, Fraser JR. (1991). Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of the rabbit. Exp Physiol, 76:125–134.
   PubMed Web of Science ®Google Scholar
• Bastianelly. (2009). Pharmaceutical composition for use in the treatment or prevention of osteoarticular deseases. International publication number: W0 2009/101210.
   Google Scholar
• Engstrom S. (1990). Drug delivery from cubic and other lipid-water phases. Lipid Technol, 2:42–45.
   Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. (2001). Cubic phase gels as drug delivery systems. Adv Drug Del Rev, 47:229–250.
   PubMed Web of Science ®Google Scholar
• Ayral X. (2001). Injections in the treatment of osteoarthritis. Best Pract Res Clin Rheumatol, 15:609–626.
   PubMed Web of Science ®Google Scholar
• Schumacher HR Jr. (2003). Aspiration and injection therapies for joints. Arthritis Rheum, 49:413–420.
   PubMed Web of Science ®Google Scholar
• Nielsen LS, Schubert L, Hansen J. (1998). Bioadhesive drug delivery systems I: Characterization of mucoadhesive properties of systems based on glyceryl monooleate and glyceryl monolinoleate. Eur J Pharm Sci, 6:231–239.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (FDA). Database of Inactive Ingredients for approved drug products, 2012. Available at: http://www.accessdata.fda.gov/scripts/cder/iig/ ( Accessed 19 july 2012).
   Google Scholar
• Kroschwitz JI. (1990). Polymers: polymer characterization and analysis; USA: a Wiley-Interscience publication. Rheological measurements:637–725.
   Google Scholar
• Guidance for Industry, Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations, September 1997, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research.
   Google Scholar
• Shah VP, Tsong Y, Sathe P, Liu J-P. (1998). In vitro dissolution profile comparison – statistics and analysis of the similarity factor f2. Pharm. Res, 15:889–896.
   PubMed Web of Science ®Google Scholar
• Ouedraogo M, Semdé R, Some IT, Traore R, Guisson IP, Evrard B, Henschel V, Dubois J, Amighi K. (2008). Monooleine-water liquid crystalline gels of gentamicin as bioresorbable implants for the local treatment of chronic osteomyelitis: in vitro characterization. Drug Dev Ind Pharm, 34:753–760.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Owen SC. Handbook of Pharmaceutical Excipients, Fifth edition, 2006:306–307.
   Google Scholar
• Neustadt DH. (2006). Intra-articular injections for osteoarthritis of the knee. Cleve Clin J Med, 73:897–8, 901.
   PubMed Web of Science ®Google Scholar
• Balazs EA. (2004). Viscoelastic properties of hyaluronan and its therapeutic use, In: Garg, Hales, ed. Chemistry and Biology of Hyaluronan, Chapter 20.
   Google Scholar
• Chang C-M, Bodmeier R. (1997). Swelling of and Drug Release from Monoglyceride-Based Drug Delivery Systems. J Pharm Sci, 86(6):747–752.
   PubMed Web of Science ®Google Scholar
• Ganem-Quintanar A, Quintanar-Guerrero D, Buri P. (2000). Monolein: A review of the pharmaceutical applications. Drug Dev Ind Pharm, 26(8):809–820.
   PubMed Web of Science ®Google Scholar
• Shah MH, Paradkar A. (2007). Effect of HLB of additives on the properties and drug release from glyceryl monooleate matrices. Eur J Pharm Biopharm, 67:166–174.
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Jasti BR. (2004). Theory and practice of contemporary pharmaceutics. Parenteral Routes of Delivery, First Edition. USA: CRC Press, 387–423.
   Google Scholar
• He R, Craig DQM. (1998). Identification of thermotropic phase transitions of glyceryl monoolein-water systems by low frequency dielectric spectroscopy. Int J Pharm, 169:131–141.
   Google Scholar